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Dyella japonica 
Bacteremia in 
Hemodialysis 
Patient
To the Editor: Patients who re-
ceive long-term hemodialysis are at 
great risk for infection (1,2), especial-
ly bacteremia, which may lead to dev-
astating outcomes (3). Environmen-
tal bacteria are commonly recovered 
from dialysis ﬂ  uid, but their contribu-
tion to infection is less evident (4). We 
report a bacteremic episode caused by 
an unusual soil bacterium, Dyella ja-
ponica. The patient was a 69-year-old 
Thai woman who had had end-stage 
renal disease for 8 months and was 
receiving hemodialysis twice a week 
via subclavian double-lumen perma-
nent catheter. Approximately 6 h af-
ter hemodialysis, she became febrile. 
Physical examination showed tem-
perature 38oC, respiratory rate 22/min, 
heart rate 80/min, and blood pressure 
130/60 mmHg. The rest of her exami-
nation was unremarkable and included 
normal state of consciousness, clear 
eyeground (fundus), and absence of a 
heart murmur. Her catheter was intact 
without evidence of exit site or cath-
eter infection.
Two blood samples, 1 each from 
the central line and peripheral line, 
were injected into BACTEC Aero-
bic/F bottles and incubated in the 
BACTEC 9240 system (Becton-Dick-
inson Diagnostic Systems, Sparks, 
MD, USA).  A catheter-related bac-
teremia was suspected, and vanco-
mycin (1 g in intravenous drip) was 
prescribed. Other laboratory ﬁ  ndings 
included a total leukocyte count 14.5 
× 109/L (84% neutrophils, 16% lym-
phocytes), blood urea nitrogen 38 mg/
dL, and creatinine 7.9 mg/dL. Urinal-
ysis results were within normal limits. 
Urine and stool cultures were negative 
for pathogenic bacteria. The catheter 
was not removed for culture. On day 
4 of incubation, both blood cultures 
showed growth, which was then 
placed onto 5% (vol/vol) sheep blood 
agar for subculture and produced deep 
yellow colonies. This uniform, gram-
negative, oxidase-positive bacterium 
was not identiﬁ  able with manual phe-
notypic tests and the API 20NE strip 
(bioMérieux, Durham, NC, USA). It 
was identiﬁ  ed by the Vitek 2 system 
(bioMérieux) and reported to be My-
roides sp. with an excellent conﬁ  dence 
level (98.7% probability).
To further conﬁ  rm the identiﬁ  ca-
tion, we used 16S rDNA analysis. The 
primer pair forward 5′-AGAGTTT
GATCMTGGCTCAG-3′ and reverse 
5′-ACGGYTACCTTGTTACGAC
TT-3′ were used to amplify the 16S 
rDNA by PCR. DNA extraction and 
PCR ampliﬁ   cation were carried out 
as described (5). The sequence of 
16S rDNA amplicon (1,450 bp) was 
determined after electrophoresis and 
performed with the 3100 Genetic 
Analyzer (Applied Biosystems, Foster 
City, CA, USA) according to the man-
ufacturer’s recommendations. The 16S 
rDNA sequence of this isolate (strain 
RB28), deposited in GenBank under 
accession no. DQ984127, was com-
pared with sequences in GenBank by 
using the BLAST algorithm (version 
2.0; National Center for Biotechnolo-
gy Information, Bethesda, MD, USA, 
www.ncbi.nlm.nih.gov/blast). Se-
quence alignment and distance analy-
sis were performed with Lasergene 
software (DNASTAR, Inc., Madi-
son, WI, USA). According to the 16S 
rDNA sequence analysis, our isolate 
belonged to the family Xanthomona-
daceae of the Gamma Proteobacteria 
class; the highest sequence similarity 
(99.2%) was obtained for D. japoni-
ca type strain XD53 (6). In contrast, 
RB28 shared <97% sequence similar-
ity to other species of Dyella and other 
genera in this family (data not shown). 
Organisms within the same species 
should share >97% of 16S rDNA se-
quence similarity (7). Therefore, this 
isolate was identiﬁ  ed as D. japonica. 
The biochemical proﬁ  le of RB28 was 
also most consistent with D. japonica 
(Table). 
MIC values as determined by 
Etest were amikacin 0.75, cefotaxime 
0.064, ceftazidime 0.38, ciproﬂ  oxacin 
<0.002, co-trimoxazole 0.125, genta-
micin 1.5, imipenem and meropenem 
0.25 mg/L. Because of MIC results, 
treatment was changed to ceftazidime 
(1 g intravenously every 8 h). Fever 
abated within a few days without cath-
eter removal. The patient had a com-
plete recovery with no complications. 
Follow-up blood cultures 2 and 4 
weeks after 14 days of treatment were 
negative.
The  Dyella genus comprises 3 
species: D. japonica (6), D. koreensis 
(8), and D. yeojuensis (9). All are soil 
isolates and have been neither isolated 
from clinical samples nor reported to 
cause human infection. Their pathoge-
nicity in humans is unknown. Because 
of its rapid onset after hemodialysis, 
the bacteremia in this patient is thought 
to have been associated with the dialy-
sis procedures. Contaminated dialyz-
ing ﬂ  uid may have been a source for 
the organism, and the permanent cath-
eter was likely to have provided an en-
try. In addition, blood culture bottles 
could have been contaminated by en-
vironmental samples. However, the 
diagnosis of catheter-related infection 
could not be deﬁ  nitive because neither 
catheter tip nor ﬂ  uid was available for 
culture. The severity of D. japonica 
bacteremia was difﬁ  cult to determine 
because the clinical manifestation was LETTERS
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mild and the patient responded well 
to antimicrobial drug therapy, albeit 
without catheter removal. This case 
emphasizes that environmental bacte-
ria can be an emerging threat for he-
modialysis patients, who are at risk of 
acquiring opportunistic infection. In 
addition, this report demonstrates the 
usefulness of molecular methods for 
identifying uncommon isolates.
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Mycobacterium 
cosmeticum, Ohio 
and Venezuela
To the Editor:  Mycobacterium 
cosmeticum is a rapidly growing non-
tuberculous mycobacteria species that 
was ﬁ  rst described in November 2004. 
The ﬁ  rst strains were obtained from 
cultures of a sink drain in a nail salon 
in Atlanta, Georgia, USA, and from a 
granulomatous lesion of a female me-
sotherapy patient in Venezuela (1).
Among 3 additional isolates of 
M. cosmeticum  obtained from July 
2003 through November 2004, one 
was obtained from a 77-year-old man 
who was admitted to Ohio hospital A 
on September 22, 2004, with fever, 
exacerbation of chronic obstructive 
pulmonary disease, and urosepsis. 
Underlying medical conditions in-
cluded diabetes, discitis, hyperlip-
idemia, coronary artery disease, and 
coal worker’s pneumoconiosis. He 
had received intravenous antimicro-
bial agents (rifampin and daptomycin) 
through a Groshong catheter that had 
been inserted to treat discitis. A rou-
tine blood culture was performed ac-
cording to standard methods (2), and 
the catheter was removed. A diagno-
sis of catheter-associated bacteremia 
(CAB) was made, but the patient’s 
overall condition improved without 
antibacterial drug therapy, and he was 
discharged 4 days after admission. The 
culture specimen yielded only my-
cobacteria and was sent on to ARUP 
Laboratories, where it was identiﬁ  ed 
as M. cosmeticum by 16S rDNA se-
quence analysis. The isolate was then 
sent to the Centers for Disease Control 
and Prevention (CDC) Mycobacteriol-
ogy Laboratory Branch (Atlanta, GA, 
USA) and designated OH1.
A 43-year-old woman with a diag-
nosis of non-Hodgkin lymphoma, who 
had received regular central venous 
catheterizations, was admitted to Ohio 
hospital B on August 20, 2004. A left 
subclavian catheter was inserted, and 
Table. Biochemical characteristics of patient’s isolate RB28 and type strains of Dyella
species*
Characteristics
 Patient’s isolate 
 RB28 
D. japonica
XD53
T
D. koreensis
BB4
T
Oxidase + + +
Catalase + + w 
Motility + + +
Acid from 
 L-arabinose  – – –
 D-galactose  – – –
 D-glucose  + + +
 D-mannose  + + –
 D-ribose  – – –
 D-sucrose  – – +
 D-xylose  – – –
 Caprate  – – –
 Citrate  – – –
α-galactosidase –– +
β-N-acetyl-glucosaminidase  –w  +
α-glucosidase –w  +
*Data from references (6) and (8); T, type strain. 